Skip to main navigation Skip to search Skip to main content

Studies from Mayo Clinic Further Understanding of Glucose Elevating Agents (Effects of Glucagon-like Peptide-1 Agonist Therapy On Vertebral Bone Mineral Density As Measured By Ct-based Hounsfield Units)

  • Melvin Helgeson

Press/Media

Period12 Mar 2026

Media coverage

1

Media coverage

  • TitleStudies from Mayo Clinic Further Understanding of Glucose Elevating Agents (Effects of Glucagon-like Peptide-1 Agonist Therapy On Vertebral Bone Mineral Density As Measured By Ct-based Hounsfield Units)
    Media name/outletDisease Prevention Daily
    Country/TerritoryUnited States
    Date12/03/26
    PersonsMelvin Helgeson